NRF-2019M3E5D3073102/National Research Foundation of Korea[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	1
2025	1

Page 1

Empagliflozin suppresses urinary mitochondrial DNA copy numbers and interleukin-1β in type 2 diabetes patients.

Lee H, Kim H, Jeon JS, Noh H, Park R, Byun DW, Kim HJ, Suh K, Park HK, Kwon SH. Lee H, et al. Sci Rep. 2022 Nov 9;12(1):19103. doi: 10.1038/s41598-022-22083-6. Sci Rep. 2022. PMID: 36351983 Free PMC article.

Fasting Glucose Variability as a Risk Indicator for End-Stage Kidney Disease in Patients with Diabetes: A Nationwide Population-Based Study.

Lee DY, Kim J, Park S, Park SY, Yu JH, Seo JA, Kim NH, Yoo HJ, Kim SG, Choi KM, Baik SH, Han K, Kim NH. Lee DY, et al. J Clin Med. 2021 Dec 18;10(24):5948. doi: 10.3390/jcm10245948. J Clin Med. 2021. PMID: 34945244 Free PMC article.

Risk acceleration by gout on major adverse cardiovascular events and all-cause death in patients with diabetes and chronic kidney disease.

Lee DY, Moon JS, Jung I, Chung SM, Park SY, Yu JH, Seo JA, Han KD, Kim NH. Lee DY, et al. Diabetes Obes Metab. 2025 Jan 2. doi: 10.1111/dom.16165. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39748223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year